Kuwait has implemented stricter regulations governing the promotion of medicines, aiming to ensure public safety and accurate information. The new rules target promotional activities by pharmaceutical companies, addressing concerns about misleading advertising and inappropriate marketing practices. Details of the regulations were not immediately available but are expected to impact how drugs are marketed to healthcare professionals and the public. This move aligns with Kuwait’s broader efforts to strengthen its healthcare system and protect patient wellbeing. Authorities believe the changes will promote rational drug use and ethical conduct within the pharmaceutical industry. The tightening of control is anticipated to improve transparency and accountability in medicine promotion within the country. These regulations follow growing international scrutiny of pharmaceutical marketing tactics.